Communiqués SSY Group Limited

Actions

2005

KYG8406X1034

Produits pharmaceutiques

Marché Fermé - Hong Kong S.E. 10:08:28 28/09/2026			Varia. 5j.	Varia. 1 janv.
2,795 ^HKD	+1,08%		+1,82%	-1,24%

16/09	SSY Group obtient l'homologation d'un principe actif pour un traitement de la schizophrénie en Chine	MT
16/09	SSY Group Limited : le mésilate de ziprasidone obtient l'homologation de l'Administration nationale des produits médicaux de Chine	CI

Communiqués

28/07/21	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
03/05/21	SSY : Proxy Form for Extraordinary General Meeting	PU
03/05/21	SSY : (1) CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING	PU
03/05/21	SSY : NOTICE OF EXTRAORDINARY GENERAL MEETING	PU
30/04/21	SSY : UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021	PU
20/04/21	SSY : PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING	PU
20/04/21	SSY : Proxy Form for Annual General Meeting 2021	PU
14/04/21	SSY : CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT	PU
12/04/21	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
25/03/21	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
18/09/20	SSY : Next Day Disclosure Return	PU
16/09/20	SSY : Next Day Disclosure Return	PU
14/09/20	SSY : Next Day Disclosure Return	PU
10/09/20	SSY : Next Day Disclosure Return	PU
21/08/20	SSY : VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT	PU
19/08/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT AND PRODUCT DEVELOPMENT	PU
29/07/20	SSY : VOLUNTARY ANNOUNCEMENT - INTRA-GROUP RESTRUCTURING FOR POSSIBLE SPIN-OFF AND SEPARATE LISTING	PU
24/02/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT	PU
20/02/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT	PU
19/02/20	SSY : INSIDE INFORMATION - Inclusion of Abidol in Diagnosis and Treatment Program for Novel Coronavirus Infected Pneumonia (Trial Version 6)	PU
06/02/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
06/02/20	SSY : EXCHANGE NOTICE - RESUMPTION OF TRADING	PU
05/02/20	SSY : INSIDE INFORMATION, UNUSUAL TRADING VOLUME AND PRICE MOVEMENTS, RESUMPTION OF TRADING	PU
05/02/20	SSY : TRADING HALT	PU
05/02/20	SSY : EXCHANGE NOTICE - TRADING HALT	PU